PACS Group, Inc. (PACS)
NYSE · Healthcare · Medical Care Facilities
PACS Group, Inc. is a Healthcare company with a market capitalization of $6.63B and a trailing P/E ratio of 27.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 11, 2026 | $0.64 | $0.41 | +56.8% |
| Q4 2025 | February 26, 2026 | $0.57 | $0.51 | +12.2% |
| Q3 2025 | November 19, 2025 | $0.32 | $0.46 | -30.4% |
| Q2 2025 | August 18, 2025 | $0.45 | $0.48 | -6.3% |
| Q1 2025 | May 19, 2025 | $0.42 | $0.40 | +5.0% |
| Q4 2024 | February 26, 2025 | $0.39 | $0.35 | +11.7% |
Other Medical Care Facilities Stocks
Frequently Asked Questions
What is PACS Group, Inc.'s market cap?
As of June 29, 2026, PACS Group, Inc. (PACS) has a market capitalization of $6.63B.
What is PACS Group, Inc.'s P/E ratio?
PACS Group, Inc. trades at a trailing price-to-earnings (P/E) ratio of 27.0. Its forward P/E is 18.5.
Does PACS Group, Inc. pay a dividend?
PACS Group, Inc. does not currently pay a dividend.
What sector is PACS in?
PACS Group, Inc. is in the Healthcare sector, specifically the Medical Care Facilities industry.
What was PACS Group, Inc.'s revenue?
In its latest reported fiscal year (ending December 31, 2025), PACS Group, Inc. reported revenue of $5.29B and net income of $191.54M.
Ask your own questions about PACS
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.